CYTK ▼ -0.6% - Cytokinetics, Incorporated $CYTK FDA Approves sNDA to Update Prescribing Information for MYQORZO (aficamten) Expanded to Include Data from Phase 3 MAPLE-HCM 16-NOV-2026 05:59 AM ET